LiMAx (Humedics GmbH) is a point-of-care diagnostic test for the quantitative measurement of the ratio of breath levels of 13 CO 2 to 12 CO 2. This can be used as a measure of functional liver ...
Humedics GmbH has announced the start of a clinical phase III trial. The main goal of this study is the early identification of low-risk patients after partial liver resection by the LiMAx test and ...
A literature search was carried out for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence ...